Events

This is a meeting with HOPO Therapeutics where they will present "Development of a new heavy metal and radionuclide decorporation agent"

HOPO Therapeutics is a startup company developing new treatments for heavy metal poisoning that are designed to be safer and more effective than existing therapies. They are working on oral medications suitable for treatment of both chronic and acute lead poisoning, and are interested in meeting stakeholders from the government and non-profit sectors who share their interests in global health.